Clinical Trial Update: Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

This update reports a Phase 1 trial of MAK683 in adults with advanced malignancies, including diffuse large B-cell lymphoma, focusing on safety and efficacy. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• MAK683

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diffuse Large B-cell Lymphoma | Phase 1 | Status: TERMINATED